Michael Jeng

Publication Details

  • Resolution of chronic hepatic sequestration in a patient with homozygous sickle cell disease receiving hydroxyurea JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY Jeng, M. R., Rieman, M. D., Naidu, P. E., Kaste, S. C., Jenkins, J. J., Serjeant, G., Wang, W. C. 2003; 25 (3): 257-260


    Hepatic sequestration is an uncommon complication in patients with homozygous sickle cell disease. Although transfusion therapy has been effective for the acute condition, no definitive treatment of chronic hepatic sequestration has been identified. We describe a 17-year-old male patient with hemoglobin SS and chronic hepatic sequestration who was treated with long-term (60 months) hydroxyurea. After 36 months of HU therapy, the patient had both an excellent hematologic response and a resolution of hepatic sequestration, as evidenced by disappearance of clinical hepatomegaly, normalization of liver volume on serial computed tomography scans, as well as decreased sinusoidal dilatation and congestion and red blood cell sickling on liver biopsy. The findings in this case suggest that hydroxyurea may benefit patients who have unusual complications of sickle cell disease, such as chronic erythrocyte sickling in the liver.

    View details for Web of Science ID 000181416800013

    View details for PubMedID 12621248

Stanford Medicine Resources:

Footer Links: